Index by author

March 1, 2015; Volume 56,Issue 3

Cover image

Cover image expansion

In a first clinical trial of prostate cancer, 18F-BAY 864367 showed favorable dosimetry, safety, and the potential of gastrin-releasing-peptide receptor imaging. See page 372.

Back to top

In this issue

Jump to